Downstaging of Stage C Prostatic Carcinoma by Inductive Chemo-Hormonal Therapy?

1993 ◽  
Vol 24 (3) ◽  
pp. 337-342 ◽  
Author(s):  
H. Kahla ◽  
J. Köllermann ◽  
M.W. Köllermann ◽  
P. Sprenk ◽  
V. Mühlfait
1980 ◽  
Vol 25 (2) ◽  
pp. 160-161
Author(s):  
J. H. Steyn

Prostatic carcinoma is a fairly common tumour and its diagnosis should always have a histological basis. Staging of the tumour by the TNM system permits a more rational approach to the choice of therapy-radical prostatectomy, radiotherapy and/or hormonal manipulation. To date there is no hormonal therapy convincingly superior to the use of oestrogen or the undertaking of bilateral orchidectomy. Chemotherapy has so far been disappointing.


BMJ ◽  
1971 ◽  
Vol 4 (5784) ◽  
pp. 391-394 ◽  
Author(s):  
M. R. G. Robinson ◽  
B. S. Thomas

Cancer ◽  
1990 ◽  
Vol 66 ◽  
pp. 1035-1038 ◽  
Author(s):  
E. David Crawford

2011 ◽  
Vol 19 (1-2) ◽  
pp. 28-30
Author(s):  
Lela Milovanovic

Hormonal treatment of prostatic carcinoma was initiated in the first half of twentieth century. Theoretical basis of hormonal treatment was established with the work of Charles Brenton Huggins published in 1941. Initial results were encouraging, but fatal outcome occurred anyway. There are four directions of hormonal treatment of pancreatic cancer: orchiectomy, estrogens, LHRH agonists, or antiandrogens. Refinements of hormonal therapy were constant and resulted in prolonged survival time and fairly improved quality of life. These results rank hormonal therapy of pancreatic cancer as the most successful systemic treatment of metastatic disease.


1991 ◽  
Vol 82 (10) ◽  
pp. 1656-1663 ◽  
Author(s):  
Akio Fujii ◽  
Nobutoshi Oka ◽  
Shigenori Miyasaki ◽  
Akihiro Higuchi ◽  
Osamu Tomioka ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document